Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Background. End-stage liver disease (ESLD) is an important cause of morbidity among human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients. Quantifying the risk of this outcome over time could help determine which coinfected patients should be targeted for risk factor modific...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Lo Re, Vincent, Kallan, Michael J., Tate, Janet P., Lim, Joseph K., Goetz, Matthew Bidwell, Klein, Marina B., Rimland, David, Rodriguez-Barradas, Maria C., Butt, Adeel A., Gibert, Cynthia L., Brown, Sheldon T., Park, Lesley S., Dubrow, Robert, Reddy, K. Rajender, Kostman, Jay R., Justice, Amy C., Localio, A. Russell
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536329/
https://ncbi.nlm.nih.gov/pubmed/26284259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofv109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados